E
Telomir Pharmaceuticals, Inc. TELO
$4.58 -$0.45-8.95%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -2.90M -5.93M -1.45M -6.25M -9.33M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges 0.00 0.00 0.00 4.34M 743.80K
Total Other Non-Cash Items 2.19M 4.81M -- -- 7.47M
Change in Net Operating Assets 100.50K 123.10K -73.80K -23.40K 23.00K
Cash from Operations -605.80K -1.00M -1.52M -1.94M -1.09M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -132.40K 132.40K -- 1.07M
Total Debt Repaid 0.00 -433.90K 0.00 -101.00K 130.00K
Issuance of Common Stock 1.04M 0.00 0.00 5.83M 90.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- 519.50K 0.00 -519.50K -200.40K
Cash from Financing 1.04M -46.90K 132.40K 5.21M 1.09M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 431.50K -1.05M -1.39M 3.27M -1.20K
Weiss Ratings